RESPONSE BIOMEDICAL CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-03-14: Reporting owner HOLLER ANTHONY F; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-03-14: Reporting owner Thompson Peter A.; Form 4/A; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-03-14: Reporting owner Shuster Lewis; Form 4/A; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-03-14: Reporting owner Wang David; Form 4/A; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-03-14 | HOLLER ANTHONY F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 40,000 owned after | $3.10 exercise price | 2013-12-12 | |
| 2013-03-14 | Thompson Peter A. Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-06-20 | |
| 2013-03-14 | Shuster Lewis Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-06-20 | |
| 2013-03-14 | Wang David Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-06-20 | |
| 2013-03-14 | KEEGAN JOSEPH D Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-06-20 | |
| 2013-03-14 | SEVERSON CLINTON Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-06-20 | |
| 2013-03-14 | Wang Jonathan Jian Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-03-19 | |
| 2013-03-14 | KEEGAN JOSEPH D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 420,000 owned after | $3.10 exercise price | 2013-03-18 | |
| 2013-03-14 | Shuster Lewis Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 420,000 owned after | $3.10 exercise price | 2013-03-18 | |
| 2013-03-14 | HOLLER ANTHONY F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $3.10 exercise price | 2013-03-18 | |
| 2013-03-14 | SEVERSON CLINTON Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 420,000 owned after | $3.10 exercise price | 2013-03-18 | |
| 2013-03-14 | Thompson Peter A. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 206,666 owned after | $3.10 exercise price | 2013-03-18 | |
| 2013-03-14 | Wang David Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 420,000 owned after | $3.10 exercise price | 2013-03-18 |